📷 Image: Hindustan Times (via NewsData)
Politics
Maharashtra FDA chief Tukaram Mundhe denies transfer rumors, pledges continued fight against unsafe food
✍️ Hindustan Times
🗓 13 Oct 2026, 06:17 AM
👁 8
FDA chief Tukaram Mundhe refuted media reports that he was being transferred, emphasizing that the state's battle against unsafe food and spurious drugs will go on.
Maharashtra's Food and Drug Administration (FDA) chief, Tukaram Mundhe, publicly denied recent media reports suggesting his transfer to another post. In a brief statement, Mundhe asserted that his role remains unchanged and that the agency will continue its vigilance against unsafe food items and counterfeit medicines across the state.
The clarification arrived shortly after the state government announced the formation of a committee on Sunday to revamp the Maharashtra Public Service Commission (MPSC), a move unrelated to the FDA's operations. While the committee's mandate focuses on recruitment reforms, speculation linked the administrative reshuffle to the FDA chief's position.
Mundhe stressed that the agency's core mission—protecting public health by monitoring food quality and drug safety—remains a priority, and no personnel changes have been decided. He urged the public and media to rely on official communications for accurate information.
The FDA continues its routine inspections and enforcement actions, aiming to curb the circulation of substandard products that pose health risks to consumers in Maharashtra.
The clarification arrived shortly after the state government announced the formation of a committee on Sunday to revamp the Maharashtra Public Service Commission (MPSC), a move unrelated to the FDA's operations. While the committee's mandate focuses on recruitment reforms, speculation linked the administrative reshuffle to the FDA chief's position.
Mundhe stressed that the agency's core mission—protecting public health by monitoring food quality and drug safety—remains a priority, and no personnel changes have been decided. He urged the public and media to rely on official communications for accurate information.
The FDA continues its routine inspections and enforcement actions, aiming to curb the circulation of substandard products that pose health risks to consumers in Maharashtra.